-
More Data on COVID-19 Vaccination and Cancer
Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.
by Anna Goshua
-
Chemobrain: It’s Not Your Imagination
Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
by Marci A. Landsmann
-
Immunotherapy Options for Breast Cancer
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
Cancer and Older Adults: Can Oncologists Do Better?
Geriatric assessment reduces toxicity from treatment and improves quality of life in older adults with cancer.
by Marci A. Landsmann
-
Registries Report on COVID-19 and Cancer
Data shed light on risk factors for death among people with cancer infected with the coronavirus.
by Kate Yandell
-
Using Leftover Cancer Drugs to Help Others
Cancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.
by Jon Kelvey
-
Facing Cancer and a Pandemic at the Same Time
Cancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other.
by Jen Tota McGivney
-
A Switch From Intravenous to Oral Chemo?
Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.
by Ashley P. Taylor
-
Possible New Treatments for Patients With Metastatic HER2-Positive Breast Cancer
Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.
by Marci A. Landsmann
-
Learning the Language of Chemotherapy
Cancer patients often do not understand words their doctors use while talking about chemotherapy, but a new video series helps explain these terms.
by Jen Tota McGivney
Cancer Talk
Results of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
by Kyle Bagenstose
Lung Cancer Patients Face Worse Survival After Wildfire ExposureResearchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.
by Sandra Gordon
Choosing Between Lung Cancer Surgery and RadiationStudy suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.
by Jon Kelvey
Understanding Disparities in Melanoma DiagnosisBlack men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.
by Kyle Bagenstose
From the AACR
-
Chemtai Mungo, MD, MPH: Bringing Cervical Cancer Treatment to More Women
An innovative self-treatment strategy for cervical precancer could save lives in low- and middle-income countries as well as underserved areas in the U.S.
-
From the Bench: Creative Approaches in Cancer Research
Insects that smell cancer, new CRISPR delivery tools, and a cancer-fighting battery—the AACR's new blog series, From the Bench, highlights creative approaches in cancer research.
Video
Ricki Fairley: Surviving and Thriving After Triple Negative Breast Cancer
